Global Leber's Hereditary Optic Neuropathy Drug Market Growth 2025-2031

October 2025 | 91 pages | ID: G6EC328DAE35EN
LP Information

Abstracts

The global Leber's Hereditary Optic Neuropathy Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the ?Leber's Hereditary Optic Neuropathy Drug Industry Forecast? looks at past sales and reviews total world Leber's Hereditary Optic Neuropathy Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Leber's Hereditary Optic Neuropathy Drug sales for 2025 through 2031. With Leber's Hereditary Optic Neuropathy Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Leber's Hereditary Optic Neuropathy Drug industry.

This Insight Report provides a comprehensive analysis of the global Leber's Hereditary Optic Neuropathy Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Leber's Hereditary Optic Neuropathy Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Leber's Hereditary Optic Neuropathy Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Leber's Hereditary Optic Neuropathy Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Leber's Hereditary Optic Neuropathy Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Leber's Hereditary Optic Neuropathy Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Elamipretide
• GS-011
• IXC-201
• KH-176
• Others

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Alkeus Pharmaceuticals, Inc.
• Biovista Inc.
• GenSight Biologics S.A.
• Ixchel Pharma, LLC
• Khondrion BV
• Spark Therapeutics, Inc.
• Stealth BioTherapeutics Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Leber's Hereditary Optic Neuropathy Drug market?
What factors are driving Leber's Hereditary Optic Neuropathy Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Leber's Hereditary Optic Neuropathy Drug market opportunities vary by end market size?
How does Leber's Hereditary Optic Neuropathy Drug break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Leber's Hereditary Optic Neuropathy Drug by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Leber's Hereditary Optic Neuropathy Drug by Country/Region, 2020, 2024 & 2031
2.2 Leber's Hereditary Optic Neuropathy Drug Segment by Type
  2.2.1 Elamipretide
  2.2.2 GS-011
  2.2.3 IXC-201
  2.2.4 KH-176
  2.2.5 Others
2.3 Leber's Hereditary Optic Neuropathy Drug Sales by Type
  2.3.1 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2020-2025)
  2.3.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Type (2020-2025)
2.4 Leber's Hereditary Optic Neuropathy Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Leber's Hereditary Optic Neuropathy Drug Sales by Application
  2.5.1 Global Leber's Hereditary Optic Neuropathy Drug Sale Market Share by Application (2020-2025)
  2.5.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Leber's Hereditary Optic Neuropathy Drug Breakdown Data by Company
  3.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Company (2020-2025)
  3.1.2 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Company (2020-2025)
3.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Company (2020-2025)
  3.2.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Company (2020-2025)
  3.2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company (2020-2025)
3.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Company
3.4 Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Product Location Distribution
  3.4.2 Players Leber's Hereditary Optic Neuropathy Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LEBER'S HEREDITARY OPTIC NEUROPATHY DRUG BY GEOGRAPHIC REGION

4.1 World Historic Leber's Hereditary Optic Neuropathy Drug Market Size by Geographic Region (2020-2025)
  4.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Leber's Hereditary Optic Neuropathy Drug Market Size by Country/Region (2020-2025)
  4.2.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Leber's Hereditary Optic Neuropathy Drug Sales Growth
4.4 APAC Leber's Hereditary Optic Neuropathy Drug Sales Growth
4.5 Europe Leber's Hereditary Optic Neuropathy Drug Sales Growth
4.6 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Growth

5 AMERICAS

5.1 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country
  5.1.1 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025)
  5.1.2 Americas Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025)
5.2 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025)
5.3 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region
  6.1.1 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region (2020-2025)
  6.1.2 APAC Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2020-2025)
6.2 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025)
6.3 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Leber's Hereditary Optic Neuropathy Drug by Country
  7.1.1 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025)
  7.1.2 Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025)
7.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025)
7.3 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug by Country
  8.1.1 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Leber's Hereditary Optic Neuropathy Drug
10.3 Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug
10.4 Industry Chain Structure of Leber's Hereditary Optic Neuropathy Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Leber's Hereditary Optic Neuropathy Drug Distributors
11.3 Leber's Hereditary Optic Neuropathy Drug Customer

12 WORLD FORECAST REVIEW FOR LEBER'S HEREDITARY OPTIC NEUROPATHY DRUG BY GEOGRAPHIC REGION

12.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size Forecast by Region
  12.1.1 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Region (2026-2031)
  12.1.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Type (2026-2031)
12.7 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Alkeus Pharmaceuticals, Inc.
  13.1.1 Alkeus Pharmaceuticals, Inc. Company Information
  13.1.2 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
  13.1.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Alkeus Pharmaceuticals, Inc. Main Business Overview
  13.1.5 Alkeus Pharmaceuticals, Inc. Latest Developments
13.2 Biovista Inc.
  13.2.1 Biovista Inc. Company Information
  13.2.2 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
  13.2.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Biovista Inc. Main Business Overview
  13.2.5 Biovista Inc. Latest Developments
13.3 GenSight Biologics S.A.
  13.3.1 GenSight Biologics S.A. Company Information
  13.3.2 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
  13.3.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 GenSight Biologics S.A. Main Business Overview
  13.3.5 GenSight Biologics S.A. Latest Developments
13.4 Ixchel Pharma, LLC
  13.4.1 Ixchel Pharma, LLC Company Information
  13.4.2 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
  13.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Ixchel Pharma, LLC Main Business Overview
  13.4.5 Ixchel Pharma, LLC Latest Developments
13.5 Khondrion BV
  13.5.1 Khondrion BV Company Information
  13.5.2 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
  13.5.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Khondrion BV Main Business Overview
  13.5.5 Khondrion BV Latest Developments
13.6 Spark Therapeutics, Inc.
  13.6.1 Spark Therapeutics, Inc. Company Information
  13.6.2 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
  13.6.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Spark Therapeutics, Inc. Main Business Overview
  13.6.5 Spark Therapeutics, Inc. Latest Developments
13.7 Stealth BioTherapeutics Inc.
  13.7.1 Stealth BioTherapeutics Inc. Company Information
  13.7.2 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
  13.7.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Stealth BioTherapeutics Inc. Main Business Overview
  13.7.5 Stealth BioTherapeutics Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Leber's Hereditary Optic Neuropathy Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Leber's Hereditary Optic Neuropathy Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Elamipretide
Table 4. Major Players of GS-011
Table 5. Major Players of IXC-201
Table 6. Major Players of KH-176
Table 7. Major Players of Others
Table 8. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2020-2025)
Table 10. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2020-2025) & ($ million)
Table 11. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2020-2025)
Table 12. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Leber's Hereditary Optic Neuropathy Drug Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Leber's Hereditary Optic Neuropathy Drug Sale Market Share by Application (2020-2025)
Table 15. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2020-2025) & ($ million)
Table 16. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2020-2025)
Table 17. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Leber's Hereditary Optic Neuropathy Drug Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Company (2020-2025)
Table 20. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company (2020-2025)
Table 22. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Producing Area Distribution and Sales Area
Table 24. Players Leber's Hereditary Optic Neuropathy Drug Products Offered
Table 25. Leber's Hereditary Optic Neuropathy Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Leber's Hereditary Optic Neuropathy Drug Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Geographic Region (2020-2025)
Table 30. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Leber's Hereditary Optic Neuropathy Drug Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country/Region (2020-2025)
Table 34. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2020-2025)
Table 38. Americas Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2020-2025)
Table 43. APAC Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Leber's Hereditary Optic Neuropathy Drug
Table 55. Key Market Challenges & Risks of Leber's Hereditary Optic Neuropathy Drug
Table 56. Key Industry Trends of Leber's Hereditary Optic Neuropathy Drug
Table 57. Leber's Hereditary Optic Neuropathy Drug Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Leber's Hereditary Optic Neuropathy Drug Distributors List
Table 60. Leber's Hereditary Optic Neuropathy Drug Customer List
Table 61. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Leber's Hereditary Optic Neuropathy Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Leber's Hereditary Optic Neuropathy Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Alkeus Pharmaceuticals, Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
Table 77. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Alkeus Pharmaceuticals, Inc. Main Business
Table 79. Alkeus Pharmaceuticals, Inc. Latest Developments
Table 80. Biovista Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
Table 82. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Biovista Inc. Main Business
Table 84. Biovista Inc. Latest Developments
Table 85. GenSight Biologics S.A. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
Table 87. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. GenSight Biologics S.A. Main Business
Table 89. GenSight Biologics S.A. Latest Developments
Table 90. Ixchel Pharma, LLC Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
Table 92. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Ixchel Pharma, LLC Main Business
Table 94. Ixchel Pharma, LLC Latest Developments
Table 95. Khondrion BV Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
Table 97. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Khondrion BV Main Business
Table 99. Khondrion BV Latest Developments
Table 100. Spark Therapeutics, Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
Table 102. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Spark Therapeutics, Inc. Main Business
Table 104. Spark Therapeutics, Inc. Latest Developments
Table 105. Stealth BioTherapeutics Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Portfolios and Specifications
Table 107. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Stealth BioTherapeutics Inc. Main Business
Table 109. Stealth BioTherapeutics Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Leber's Hereditary Optic Neuropathy Drug
Figure 2. Leber's Hereditary Optic Neuropathy Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Leber's Hereditary Optic Neuropathy Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country/Region (2024)
Figure 10. Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Elamipretide
Figure 12. Product Picture of GS-011
Figure 13. Product Picture of IXC-201
Figure 14. Product Picture of KH-176
Figure 15. Product Picture of Others
Figure 16. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type in 2025
Figure 17. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2020-2025)
Figure 18. Leber's Hereditary Optic Neuropathy Drug Consumed in Hospital
Figure 19. Global Leber's Hereditary Optic Neuropathy Drug Market: Hospital (2020-2025) & (K Pcs)
Figure 20. Leber's Hereditary Optic Neuropathy Drug Consumed in Clinic
Figure 21. Global Leber's Hereditary Optic Neuropathy Drug Market: Clinic (2020-2025) & (K Pcs)
Figure 22. Leber's Hereditary Optic Neuropathy Drug Consumed in Others
Figure 23. Global Leber's Hereditary Optic Neuropathy Drug Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Leber's Hereditary Optic Neuropathy Drug Sale Market Share by Application (2024)
Figure 25. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application in 2025
Figure 26. Leber's Hereditary Optic Neuropathy Drug Sales by Company in 2025 (K Pcs)
Figure 27. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Company in 2025
Figure 28. Leber's Hereditary Optic Neuropathy Drug Revenue by Company in 2025 ($ millions)
Figure 29. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company in 2025
Figure 30. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Leber's Hereditary Optic Neuropathy Drug Sales 2020-2025 (K Pcs)
Figure 33. Americas Leber's Hereditary Optic Neuropathy Drug Revenue 2020-2025 ($ millions)
Figure 34. APAC Leber's Hereditary Optic Neuropathy Drug Sales 2020-2025 (K Pcs)
Figure 35. APAC Leber's Hereditary Optic Neuropathy Drug Revenue 2020-2025 ($ millions)
Figure 36. Europe Leber's Hereditary Optic Neuropathy Drug Sales 2020-2025 (K Pcs)
Figure 37. Europe Leber's Hereditary Optic Neuropathy Drug Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue 2020-2025 ($ millions)
Figure 40. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2025
Figure 41. Americas Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2020-2025)
Figure 42. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2020-2025)
Figure 43. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2020-2025)
Figure 44. United States Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region in 2025
Figure 49. APAC Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2020-2025)
Figure 50. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2020-2025)
Figure 51. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2020-2025)
Figure 52. China Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. India Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2025
Figure 60. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2020-2025)
Figure 61. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2020-2025)
Figure 62. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2020-2025)
Figure 63. Germany Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 64. France Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2020-2025)
Figure 71. Egypt Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Leber's Hereditary Optic Neuropathy Drug in 2025
Figure 77. Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug
Figure 78. Industry Chain Structure of Leber's Hereditary Optic Neuropathy Drug
Figure 79. Channels of Distribution
Figure 80. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Forecast by Region (2026-2031)
Figure 81. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Application (2026-2031)